Fat deposits constrict people's arteries and reduce blood flow leading to atherosclerosis. People with clogged arteries are more susceptible to heart attacks, strokes, and foot blood vessel narrowing. Chelation treatment includes injecting chemicals thought to remove metals from the circulation into the patient's bloodstream. People with atherosclerotic cardiovascular disease may benefit from this therapy to clear blockages from their blood arteries. Although little is known about it, chelation therapy is used as an alternate kind of treatment in many countries worldwide. Oral chelation therapy for atherosclerosis: Chelation therapy, a complementary medicine, is advocated and used worldwide to treat atherosclerotic cardiovascular disease. It is suggested as a secure, reasonably priced, non-surgical way to get the blood flowing again in atherosclerotic arteries. The effectiveness of oral chelation therapy for atherosclerosis is still debatable.
Chelation therapy for angina: Chelation treatment is a chemical technique used to bind metals or minerals so they may be expelled from the body. Chelation is used in traditional medicine to treat conditions such as severe lead toxicity and iron overload. It is used to treat angina. When chelation therapy for angina is recommended, a medical professional infuses a disodium EDTA solution via the veins in a series of infusions. A course of treatment may call for 20 to 40 several-hour-long infusions administered once a week.
Additionally, patients frequently take vitamins a
nd minerals in large doses. The use of chelation therapy for angina and other types of atherosclerotic disease increased during the next 50 years following Clarke's first report due to numerous findings and despite the absence of well-powered clinical trials to assess its efficacy. Due to its unchecked usage, EDTA chelation for cardiovascular illness has been supported by several case reports and series, some of which are lengthy.
For more than 50 years, doctors have used oral chelation treatment to treat atherosclerosis. Traditional practitioners stopped using it in the 1960s and 1970s due to a lack of convincing evidence. Chelation treatment was thus confined to complementary and alternative medicine specialists, who claimed positive anecdotal outcomes. The best current data is not supported by the therapeutic use of oral EDTA chelation therapy for atherosclerosis in the treatment of heart disease. Using EDTA chelation treatment instead of an established therapy may result in indirect damage to the patient, even though it is not considered a highly invasive or hazardous therapy.
